Pharmaceutical Executive is proud to announce that it has been awarded a 2022 APEX Award of Excellence for its Pharmaceutical Executive Podcast.
The Pharm Exec podcast, which debuted in 2018, features interesting and engaging c-suite-level leaders in the pharma, biopharma, and biotech space who can share unique, helpful, and non-promotional business insights with the intention of helping educate, inspire, and enlighten their fellow leaders. Currently up to 112 biweekly episodes and counting, the podcast is co-hosted by Editor-in-Chief, Elaine Quilici, and Group Social Media Editor, Miranda Schmalfuhs. Pharm Exec would also like to recognize the podcast’s original co-hosts, Christen Harm and Michelle Maskaly.
For more information on the Pharm Exec podcast and how to get involved, read the FAQs in the following link.
PE Podcast FAQsThe APEX Awards are based on excellence in graphic design, editorial content, and the ability to achieve overall communications excellence. APEX Grand Awards honor the outstanding works in each main category, while APEX Awards of Excellence recognize exceptional entries in each of the individual subcategories. After more than 1,200 entries, 100 Grand Awards were presented to work in 14 major categories, and 485 Awards of Excellence in 100 subcategories.
The panel of judges for APEX 2022 included Ken Turtoro, APEX Senior Judge and Concepts Executive Editor; John De Lellis, Concepts Editor & Publisher; Christine Turner, Contributing Editor of the Writing That Works Archives; and John Tavaska, Consulting Editor.
To view the full list of APEX entries, click here.
Pricing Climate Impacting Commercial Considerations
May 3rd 2024In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.